Skip to main content

Your search for “immunotherapy” returned 127 results

Surfers and Philanthropists Unite in the Fight Against Cancer Aug. 9

July 27, 2015

A fundraiser like no other, the Luau and Legends of Surfing Invitational trades tuxedos and ballrooms for surfboards and sand. The San Diego tradition, now in its 22nd year, features a surf competition that draws scientists, community members and surf legends alike. Afterward, guests will enjoy a Hawaiian-themed luau with…

UC San Diego Named Top 10 Public University by U.S. News & World Report

September 13, 2021

U.S. News & World Report has once again named the University of California San Diego among the best colleges in the country. Released today, the U.S. News & World Report 2022 Best Colleges rankings listed UC San Diego as the nation’s eighth best public university.

Elizabeth Villa Selected as 2021 HHMI Investigator

September 23, 2021

Biological Sciences Associate Professor Elizabeth Villa has been selected as a 2021 Howard Hughes Medical Institute (HHMI) Investigator. As one of 33 scientists chosen out of pool of more than 800, Villa will receive $9 million over a seven-year HHMI Investigator term.

Blood Biopsy Reveals Unique, Targetable Genetic Alterations in Patients with Rare Cancer

August 15, 2017

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer

April 22, 2019

University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.

Extrachromosomal DNA is common in human cancer and drives poor patient outcomes

August 17, 2020

The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. 17, 2020 by a team of researchers including the University of California San Diego.

Aversion to Risk by R&D Managers May Hurt U.S. Economic Prospects

March 16, 2020

Research and Development (R&D) has long been key in the U.S.’s economic prospects and according to new research from the University of California San Diego, the country’s ability to maintain its competitive edge in this area largely depends on managers in R&D being less averse to risk.

Iris and Matthew Strauss Give $2 Million to Endow Faculty Chair at UC San Diego

June 22, 2021

Longtime supporters of cancer research and patient care at Moores Cancer Center at UC San Diego Health have given University of California San Diego School of Medicine $2 million to establish the Iris and Matthew Strauss Chancellor’s Endowed Chair in Head and Neck Surgery.

Taking One for the Team: How Bacteria Self-Destruct to Fight Viral Infections

January 10, 2020

UC San Diego School of Medicine researchers have discovered how a new immune system works to protect bacteria from phages, viruses that infect bacteria — new information that could be leveraged to improve treatment of multidrug-resistant bacterial infections by refining phage therapy.

Next Generation Precision Oncology Symposium Celebrates Survivors, Current and Future

February 15, 2019

The Next Generation Precision Oncology Symposium, a novel meeting of industry and academic leaders in cancer science and medicine, will be held February 21, 2019 at UC San Diego Moores Cancer Center.

Category navigation with Social links